Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma

Purpose A phase II trial was conducted to evaluate the therapeutic efficacy and safety profiles of frontline concurrent chemoradiotherapy (CCRT) plus consolidation chemotherapy for patients with stage I/II nasal natural killer/T‐cell lymphoma (NKTCL). Patients and methods Patients with newly diagnos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of haematology 2015-02, Vol.94 (2), p.130-137
Hauptverfasser:	Tsai, Hui-Jen, Lin, Sheng-Fung, Chen, Chu-Chih, Chen, Tsai-Yun, Su, Wu-Chou, Hwang, Wen-Li, Lin, Jin-Ching, Chiou, Tzeon-Jye, Kao, Weio-Yau, Chiu, Chang-Fang, Chang, Yi-Fang, Chang, Jeffrey S., Chang, Ming-Chih, Su, Ih-Jen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemoradiotherapy - adverse effects Combined Modality Therapy concurrent chemoradiotherapy Consolidation Chemotherapy Female Humans localized Lymphoma, Extranodal NK-T-Cell - mortality Lymphoma, Extranodal NK-T-Cell - pathology Lymphoma, Extranodal NK-T-Cell - therapy Male Medication Adherence Middle Aged nasal natural killer/T-cell lymphoma Neoplasm Staging Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!